Cargando…
Semifluorinated Alkanes as New Drug Carriers—An Overview of Potential Medical and Clinical Applications
Fluorinated compounds have been used in clinical and biomedical applications for years. The newer class of semifluorinated alkanes (SFAs) has very interesting physicochemical properties including high gas solubility (e.g., for oxygen) and low surface tensions, such as the well-known perfluorocarbons...
Autores principales: | Tsagogiorgas, Charalambos, Otto, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146824/ https://www.ncbi.nlm.nih.gov/pubmed/37111696 http://dx.doi.org/10.3390/pharmaceutics15041211 |
Ejemplares similares
-
Inhalationally Administered Semifluorinated Alkanes (SFAs) as Drug Carriers in an Experimental Model of Acute Respiratory Distress Syndrome
por: Otto, Matthias, et al.
Publicado: (2021) -
Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease
por: Steven, Philipp, et al.
Publicado: (2017) -
Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease—A Prospective, Multicenter Noninterventional Study
por: Steven, Philipp, et al.
Publicado: (2015) -
A Low Concentration of Tacrolimus/Semifluorinated Alkane (SFA) Eyedrop Suppresses Intraocular Inflammation in Experimental Models of Uveitis
por: De Majumdar, S., et al.
Publicado: (2017) -
A semifluorinated alkane (F4H5) as novel carrier for cyclosporine A: a promising therapeutic and prophylactic option for topical treatment of dry eye
por: Gehlsen, Uta, et al.
Publicado: (2017)